Article
What Are The Top Hatch-Waxman And BPCIA Developments For July 2018?
This month, we highlight significant developments from July 2018, including the FDA's Biosimilar Action Plan for "reducing gaming of FDA requirements or other attempts to unfairly delay competition" ...

Morrison Foerster





